13F

Stock

RedHill Biopharma Ltd.

RDHL · held by 16 managers

Reported value

$386.5K

Holders

16

+3 new · −4 exited

Holders’ est. mark

−$132K

Price effect on 13 books still in the name

Largest holder

$261.5K

Yorkville Advisors Global, LP

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Yorkville Advisors Global, LP350.9K$261.5K−$99.9KCut−$136.7K
GAGNON SECURITIES LLC88.4K$65.9K−$24.5KCut−$22.8K
Citadel20.7K$15.4K−$4.41KCut−$535
XTX Topco Ltd15.2K$11.3KNew
StoneX Group Inc.14.5K$10.8KNew
TWO SIGMA SECURITIES, LLC13K$9.7KNew
GAMMA Investing LLC6.68K$4.98K−$1.38KAdded$8
RHUMBLINE ADVISERS5.12K$3.81K−$762Added$1.05K
Federation des caisses Desjardins du Quebec3.39K$2.52K−$966Cut−$966
UBS Group AG826$615−$5Added$597
Your Advocates Ltd., LLP19$14−$6Cut−$6
Smartleaf Asset Management LLC5$4−$1Cut−$1
SBI Securities Co., Ltd.4$3−$1Cut−$1
Vermillion Wealth Management, Inc.2$1−$1Cut−$1
MORGAN STANLEY1$1$0Held
ROYAL BANK OF CANADA1$0$0Held

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.